Longevity medicine has gone peptide-crazy
If there's a word that captures both the great promise and the persistent uncertainty of longevity medicine, it's peptides.
22 hours ago
0
3
Chemical Actions and Uses: News and Research on Chemical Actions and Uses
MeSH tree: D27
Different GLP-1 therapies could be tailored to patients' individual metabolic needs
Different varieties and doses of GLP-1 medications can have meaningful differences in how they address heart and metabolic health issues, according to new research led by the Perelman School of Medicine at the University ...
Jul 27, 2026
0
3
Autoantibodies could shape cancer risk, growth and response to immunotherapy
Scientists have long sought to understand why some people with no known risk factors develop cancer while others with significant risk never do. The answer may lie in immune proteins known as autoantibodies (auto-Abs), suggests ...
Jul 25, 2026
0
47
Distinct brain circuits explain contradictory behaviors of new weight-loss drugs
Cambridge scientists have solved the mystery of why both stimulating and blocking a particular "switch" in the brain can help people lose weight—findings that could help boost the effectiveness of obesity drugs.
Jul 24, 2026
0
417
Novel neurointerventional procedure shows early promise for severe back pain
Researchers at the Society of NeuroInterventional Surgery (SNIS) 23rd Annual Meeting presented an experimental neurointerventional technique designed to treat severe back pain, a leading cause of disability and opioid use, ...
Jul 23, 2026
0
4
New strategy could prevent T cell exhaustion and boost immunotherapy
A major pillar of cancer immunotherapy involves stimulating T cells, the specialized killers of the immune system, to attack tumors. But this strategy has been undermined by the tendency of T cells to tire out before finishing ...
Jul 23, 2026
0
104
Cerebral small vessel disease: New treatment possibilities for the little‑known condition affecting millions of people
Cerebral small vessel disease (CSVD), which notably increases the risk of stroke and cognitive disorders, is estimated to affect more than 5 million people in France alone. In the absence of a curative treatment, preventing ...
Jul 23, 2026
0
5
GLP-1 diabetes drugs linked to up to 68% higher hair loss risk
The use of glucagon-like peptide-1 (GLP-1) receptor agonists to treat type 2 diabetes and obesity is associated with an increased risk of hair loss (alopecia) in adults with type 2 diabetes, a study published by The BMJ finds. ...
Jul 22, 2026
0
27
Same carcinogen, different tumors: Mouse study reveals the role of genetic background
Why do cancers develop differently in different people—even when they are exposed to the same risk factors? An international research group, including the German Cancer Research Center (DKFZ), has demonstrated in mice that ...
Jul 22, 2026
0
3
Study links prenatal opioid exposure to long-term challenges in children's vision and behavior
Children exposed to opioids before birth may face increased risks of difficulties with vision, attention, behavior and learning during their school years, according to a new study.
Jul 22, 2026
0
2
